This back cover shows a novel delivery vehicle of RNA nanoparticle (named RIONmiR-143) for RAS-mutated intractable cancers. Tumor-suppressor microRNA-143 (miR-143) silences oncogenic KRAS networks, but it lacks nucleic acid clinical application. research creates the RIONmiR-143 by self-assembly miR-143s and demonstrates functions.